Richard Shemilt, Michael K Sullivan, Peter Hanlon, Bhautesh Jani, Nicole De La Mata, Brenda Rosales, Benjamin M P Elyan, James A Hedley, Rachel B Cutting, Melanie Wyld, David A McAllister, Angela C Webster, Patrick B Mark, Jennifer S Lees
BACKGROUND AND HYPOTHESIS: People with chronic kidney disease (CKD) have increased incidence and mortality from most cancer types. We hypothesised that odds of presenting with advanced cancer may vary according to differences in eGFR, that this could contribute to increased all-cause mortality and that sex differences may exist. METHODS: Data were from Secure Anonymised Information Linkage Databank, including people with de-novo cancer diagnosis (2011-2017) and two kidney function tests within two years prior to diagnosis to determine baseline eGFR (mL/min/1...
March 9, 2024: Nephrology, Dialysis, Transplantation